About Enantigen

Enantigen Therapeutics, Inc. is an innovative pharmaceutical company located at the Pennsylvania Biotechnology Center and striving for excellence in the discovery, development and commercialization of novel drugs to treat life-threatening infectious diseases. The primary focus is on the development of oral therapeutics for the treatment of hepatitis B.